إعلان
إعلان

ANIX

ANIX logo

Anixa Biosciences, Inc.

3.39
USD
برعاية
-0.03
-0.91%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

3.47

+0.08
+2.39%

تقارير أرباح ANIX

النسبة الإيجابية المفاجئة

ANIX تفوق 20 من 28 آخر التقديرات.

71%

التقرير التالي

بيانات التقرير القادم
٠٩ مارس ٢٠٢٦
Estimate for Q1 26 (Revenue/ EPS)
--
/
-$0.10
التغير الضمني من Q4 25 (Revenue/ EPS)
--
/
--
التغير الضمني من Q1 25 (Revenue/ EPS)
--
/
--

Anixa Biosciences, Inc. earnings per share and revenue

On ٠٨ يناير ٢٠٢٦, ANIX reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of -0.08 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -1.17% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 5 المحللين forecast an EPS of -0.10 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
الأسئلة الشائعة
For Q4 2025, Anixa Biosciences, Inc. reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.
The stock price moved down -1.17%, changed from $3.42 before the earnings release to $3.38 the day after.
The next earning report is scheduled for ٠٩ مارس ٢٠٢٦.
Based on 5 المحللين, Anixa Biosciences, Inc. is expected to report EPS of -$0.10 and revenue of -- for Q1 2026.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان